相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants
Nicole S. Delino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Design of Highly Potent, Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants
Arun K. Ghosh et al.
CHEMMEDCHEM (2018)
Mechanism of Darunavir (DRV)'s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance
Manabu Aoki et al.
MBIO (2018)
Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception
Rebecca Zash et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis
S. Teeraananchai et al.
HIV MEDICINE (2017)
Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update
Robert W. Shafer
JOURNAL OF INFECTIOUS DISEASES (2017)
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency
Manabu Aoki et al.
ELIFE (2017)
Improved life expectancy of people living with HIV: who is left behind?
Ingrid T. Katz et al.
LANCET HIV (2017)
GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane-Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro
Masayuki Amano et al.
SCIENTIFIC REPORTS (2017)
Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care
Julia L. Marcus et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2016)
International AIDS Society global scientific strategy: towards an HIV cure 2016
Steven G. Deeks et al.
NATURE MEDICINE (2016)
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
M. S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Psychiatric disorders after starting dolutegravir: report of four cases
Farid Kheloufi et al.
AIDS (2015)
Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis
Carlos Mata-Munguia et al.
BMC BIOINFORMATICS (2014)
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Bonaventura Clotet et al.
LANCET (2014)
Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir
Hironori Hayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
On the Solubility and Lipophilicity of Metallacarborane Pharmacophores
Jakub Rak et al.
MOLECULAR PHARMACEUTICS (2013)
A convenient chemical-microbial method for developing fluorinated pharmaceuticals
Tara V. Bright et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada
Hasina Samji et al.
PLOS ONE (2013)
Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors
Yunfeng Tie et al.
PROTEIN SCIENCE (2012)
Loss of Protease Dimerization Inhibition Activity of Darunavir Is Associated with the Acquisition of Resistance to Darunavir by HIV-1
Yasuhiro Koh et al.
JOURNAL OF VIROLOGY (2011)
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
High Genetic Barrier Antiretroviral Drugs in Human Immunodeficiency Virus-Positive Pregnancy
Maurizio Zazzi
CLINICAL INFECTIOUS DISEASES (2010)
In Vitro Selection of Highly Darunavir-Resistant and Replication-Competent HIV-1 Variants by Using a Mixture of Clinical HIV-1 Isolates Resistant to Multiple Conventional Protease Inhibitors
Yasuhiro Koh et al.
JOURNAL OF VIROLOGY (2010)
Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients
Sandra De Meyer et al.
AIDS (2009)
Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis
Thomas Ryckmans et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability
Michael J. Waring
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Fluorine Bonding - How Does It Work In Protein-Ligand Interactions?
Peng Zhou et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
HIV-1 Protease: Structural Perspectives on Drug Resistance
Irene T. Weber et al.
VIRUSES-BASEL (2009)
Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
Roberto Ortiz et al.
AIDS (2008)
Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease
Jane M. Sayer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Fluorinated nucleosides: Synthesis and biological implication
Peng Liu et al.
JOURNAL OF FLUORINE CHEMISTRY (2008)
Prevalence of darunavir resistance-associated mutations: Patterns of occurrence and association with past treatment
Yumi Mitsuya et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization
Yasuhiro Koh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN:: a randomised controlled phase III trial
Jose Valdez Madruga et al.
LANCET (2007)
Adsorption of drugs onto a pH responsive poly(N,N-dimethyl aminoethyl methacrylate) grafted anion-exchange membrane in vitro
Jouni Karppi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2:: a pooled subgroup analysis of data from two randomised trials
Bonaventura Clotet et al.
LANCET (2007)
The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability
Frank H. Niesen et al.
NATURE PROTOCOLS (2007)
TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates
S De Meyer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site
B Mahalingam et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Halogen bonds in biological molecules
P Auffinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
分享论文
